NCT03895008招募中不适用
Comparing the Stage-for-Stage Prognosis of Patients With Cardia and Non-cardia Gastric Cancer After Operation.
Affiliated Hospital of Qinghai University3 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2019年7月8日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 1,000
- 试验地点
- 3
- 主要终点
- Disease Free Survival（DFS）
研究概览
简要总结
To comparing the stage-for-stage prognosis of patients with cardia and non-cardia gastric cancer after operation.
详细描述
The aim of this study is to compare the stage-for-stage prognosis of patients with cardia and non-cardia gastric cancer after operation.In this study, patients with cardiac and non-cardiac gastric cancer who undergo radical resection from January 2019 to December 2024 will be included. We will follow up the patient's progression, recurrence time and survival time.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Histopathology or cytopathology proven cardia or non-cardia gastric cancer;
- •Operable gastric cancer patients: primary lesions can be completely excision, no distant metastasis;
- •Life expectancy of at least 6 months;
- •ECOG（Eastern Cooperative Oncology Group ） score 0-1;
- •Age: 18~80 years old;
- •Normal hemodynamic indices before the recruitment (including blood cell count and liver/kidney function).
- •For example: WBC（White blood cell count ）>4.0×109/L; NEU（Neutrophils）>1.5×109/L; PLT（Platelet）>100×109/L;
- •Roughly normal cardiopulmonary function: No coronary heart disease, myocardial infarction, pulmonary heart disease, refractory hypertension;
- •Not concomitant with other uncontrollable benign diseases before the recruitment;
- •Voluntarily signed the informed consent.
排除标准
- •Advanced gastric cancer patients with distant metastasis and inoperable ;
- •Pregnant or lactating women;
- •Patients who have no desire to participate in the study.
结局指标
主要结局
Disease Free Survival（DFS）
时间窗: 5 years
The time from the primary operation to disease recurrence or death.
次要结局
- Overall survival(OS)(5 years)
研究者
Jiuda Zhao
Professor
Affiliated Hospital of Qinghai University
研究点 (3)
Loading locations...
相似试验
已完成
不适用
Comparison of Long-term Outcomes Between Upfront Surgery and Neoadjuvant Therapy Followed by Surgery in Patients with Node-Negative Gastric CancerLymph Node-negativeGastric CancerNCT06673472Chang-Ming Huang, Prof.1,081
Unknown
不适用
Study of CT and MR in the Gastric CancerGastric Cancer StageCTMRINeoadjuvant TherapyNCT04028375Henan Cancer Hospital400
已完成
不适用
Prognostic Performance of the Naples Prognostic ScoreNutritional and Metabolic DiseasesOncologic DisordersNCT03272646University of Campania "Luigi Vanvitelli"477
Unknown
不适用
Predictive Biomarkers in Stage II/III Gastric Cancer for Adjuvant ChemotherapyGastric CancerNCT01905969Iwate Medical University500
招募中
不适用
Effect of Different Treatments on the Prognosis of Early Cervical Cancer: A Multicenter, Prospective, Real-world StudyCervical CancerNCT04272190Southern Medical University, China20,000